Annual Report 2015-2016 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2015-2016. During the financial year, The Company’s Total Revenue Rs. 80,462.8 million. Net Profit after Tax for the year Rs. 10,733.6 million. The dividend on Equity shares Rs. 2,406.8. Book value per equity share of Rs.1/- each Rs. 89/-. During the financial year, The Company has also allotted 25,460 equity shares under Sun Employee Stock Option Scheme – 2015 on 2^nd May 2016 and paid up share capital of the Company increased from Rs. 2,40,67,28,499/- to Rs. 2,40,67,53,959/-.

The Board of Directors is pleased to recommend an equity dividend of Rs. 1/- (Rupee One only) per equity share of face value of Rs. 1/- (Rupee One only) each (previous year Rs. 3/- (Rupees Three only) per equity share) for the year ended 31^st March 2016, subject to the approval of the shareholders at the ensuing Annual General Meeting.

More Annual Report of Sun Pharmaceutical Industries Limited: